Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 3, 2017
- Accepted for publication November 30, 2017
- Published online March 1, 2018.
Article Versions
- previous version (December 14, 2017 - 09:27).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Jeremie Calais1,
- Wolfgang P. Fendler1,
- Matthias Eiber1,
- Jeannine Gartmann1,
- Fang-I Chu2,
- Nicholas G. Nickols2,
- Robert E. Reiter3,
- Matthew B. Rettig3,
- Leonard S. Marks3,
- Thomas E. Ahlering4,
- Linda M. Huynh4,
- Roger Slavik1,
- Pawan Gupta1,
- Andrew Quon1,
- Martin S. Allen-Auerbach1,
- Johannes Czernin1 and
- Ken Herrmann1
- 1Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California
- 2Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California
- 3Department of Urology, UCLA Medical Center, Los Angeles, California; and
- 4Department of Urology, UC Irvine Health, Irvine, California
- For correspondence or reprints contact: Jeremie Calais, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., Medical Plaza 200, Suite B114-61, Los Angeles, CA 90095. E-mail: jcalais{at}mednet.ucla.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Clinical Factors That Influence Repeat 68Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative 68Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study
- Feasibility of 99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
- A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients
- Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
- Detection Efficacy of 18F-rhPSMA-7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment
- Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
- Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
- Automated analysis of PSMA-PET/CT studies using convolutional neural networks
- Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
- Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
- Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
- Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence--A Narrative Review of the Literature
- Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
- Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis
- Outcome After PSMA PET/CT-Based Salvage Radiotherapy in Patients with Biochemical Recurrence After Radical Prostatectomy: A 2-Institution Retrospective Analysis
- The National Oncologic PET Registry (NOPR): A Monumental Effort by a Few Leaders
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement